Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by Super63

ACST

Francine

Thank you for all the great posts. I find them credible and informative...

January 3, 2020

ACST

new reason to invest here

https://www.bnnbloomberg.ca/investing/video/robert-mcwhirter-discusses-acasti...

December 29, 2019

ACST

2020 BO?

https://finance.yahoo.com/news/pharma-m-deals-likely-smaller-211240580.html...

December 26, 2019

ACST

Francine

beginning to suspect you were telling us the truth the whole time

December 22, 2019

ACST

License fee

Eddingpharm Starts China Trial of Amarin's Hypertriglyceridemia Treatment...

December 15, 2019

ACST

Hooray!

$ACST great news! They can now frame P3 data around treating diabetic high TG...

December 13, 2019

ACST

Well?

We're Waiting!

December 13, 2019

ACST

My thesis here. what's yours?

BuzzandAndy09:20 AM $ACST Ya'll met the big investor...

December 13, 2019

ACST

Phospholipid advantage

Acasti’s prescription drug candidate, CaPre, is a highly purified omega-3...

December 10, 2019

ACST

China

22.44 ...

December 8, 2019

ACST

2nd prong in the trident Capre trifecta

ACST My hypothesis here is that higher doses of Capre will dramatically...

December 7, 2019

ACST

all just a coincidence?

$ACST One has to consider what exactly did they show Terren P to get him to...

December 6, 2019

ACST

your future

$ACST Once FDA expands amm label the omg3 space will get coverage in...

December 4, 2019

ACST

Are shorts aware of this?

Does the AMRN study in China with Eddingpharm pave the way for Capre...

November 24, 2019

ACST

https://seekingalpha.com/article/4308236-acasti-pharma-winni

$20 BO speculation     so, they held a 2 day this month...

November 21, 2019

ACST

now calling Capre cardio candy

If EVAPORATE study tomorrow goes well coupled with this stint news- Wow...

November 17, 2019

ACST

accumulating

Renaissance Technologies LLC opened position in Acasti in Q3 with 251k shares...

November 14, 2019

ACST

Read the transcript

I found Jan's points about phospholipids being the key advantage for...

November 14, 2019

ACST

Baby its cold outside

but we got a nice fire going in here!

November 12, 2019

ACST

AMRN REDUCE -IT

30% decline in overall death. OMG! 3

November 11, 2019

Prev 1 2 3 Next

Featured Company

Nanalysis Scientific Corp.

Nanalysis Scientific Corp. V.NSCI

Nanalysis develops and manufactures compact MRI and NMR devices for clinical, laboratory, and industrial markets. These ... view more »